SCHEMBL1611486

SCHEMBL1611486

[CH]=CCCCc1ccc(C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP2A6 P11509 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
IGF1R P08069 1/20 0.46
ALOX15 P16050 1/20 0.46
HRH1 P35367 1/20 0.42
IDO1 P14902 1/20 0.39
KCNH2 Q12809 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
AGXT P21549 1/20 0.35
CHRM2 P08172 1/20 0.35
CHKA P35790 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
PLAAT3 P53816 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610334 0.94 IGF1R (0.48) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1610374 0.92 IGF1R (0.47) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1610738 0.92 IGF1R (0.47) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1611960 0.86 CYP1A2 (0.50) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1611191 0.83 TAAR1 (0.46) CYP2A6TAAR1CHRM2ALDH1A1GPR84
SCHEMBL1609636 0.83 CA2 (0.48) CHRM2ALDH1A1
SCHEMBL1612553 0.83 LPL (0.42) CHRM2ALDH1A1
SCHEMBL1610189 0.81 ESR1 (0.53) CHRM2MEN1ALDH1A1KMT2A
SCHEMBL11639779 0.80 CYP1A2 (0.48) CYP1A2CYP2A6TAAR1IGF1RALOX15
SCHEMBL1610578 0.79 ESR1 (0.57) CHRM2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110087034-A1 Organic Semiconductor Material SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2011-04-14 US disclosed
EP-2248818-A1 ORGANIC SEMICONDUCTOR MATERIAL Sumitomo Chemical Company, Limited (JP) 2010-11-10 EP disclosed
EP-0891331-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY Vertex Pharmaceuticals Incorporated (US) 1999-01-20 EP disclosed
WO-1997036869-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110087034-A1 Organic Semiconductor Material OR10J3, TST, OR51E2 CYP1A2 125/4885CYP2A6 1465/4885TAAR1 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.